Abstract

We have investigated the basis for the striking difference between the broad DNA sequence selectivity of the c-Myb transcription factor minimal DNA-binding domain R(2)R(3) in vitro and the more restricted preference of a R(2)R(3)VP16 protein for Myb-specific recognition elements (MREs) in a Saccharomyces cerevisiae transactivation system. We show that sequence discrimination in yeast is highly dependent on the expression level of Myb effector protein. Full-length c-Myb and a C-terminally truncated protein (residues 1-360) were also included in the study. All of the tested Myb proteins displayed very similar DNA binding properties in electrophoretic mobility shift assays. Only minor differences between full-length c-Myb and truncated c-Myb(1-360) were observed. In transactivation studies in CV-1 cells, the MRE selectivity was highest at low expression levels of Myb effector proteins. However, the discrimination between MRE variants was rapidly lost with high input levels of effector plasmid. In c-Myb-expressing K-562 cells, the high degree of MRE selectivity was retained, thereby confirming the relevance of the results obtained in the yeast system. These data suggest that the MRE selectivity of c-Myb is an intrinsic property of only the R(2)R(3) domain itself and that the transactivation response of a specific MRE in vivo may be highly dependent on the expression level of the Myb protein in the cell.

Highlights

  • The c-Myb protein is a transcription factor encoded by the c-myb proto-oncogene

  • The Myb-specific recognition elements (MREs) Selectivity of R2R3VP16 in Vitro and in Vivo in Mammalian Cells—We have previously demonstrated that recombinant c-Myb R2R3 can bind well to MRE variants containing a guanine in positions 5 and/or 6 of the consensus core MRE TAACNG as analyzed by electrophoretic mobility shift assay (EMSA)

  • A CMV-based expression plasmid for chicken c-Myb minimal DNA-binding domain R2R3 fused to the VP16 transactivation domain, R2R3VP16, was transfected into COS-1 cells, and whole-cell lysates were used as the protein source for EMSA

Read more

Summary

Introduction

The c-Myb protein is a transcription factor encoded by the c-myb proto-oncogene (reviewed in Refs. 1–3). The majority of retroviral insertions in the c-myb gene result in N-terminal truncations of the c-Myb protein and deregulated expression, leading to myeloid leuke-. Polymerase chain reaction-based binding-site selection methods with Myb proteins resulted in minor extensions of the MRE consensus sequence [15, 16]. Sequence substitutions in the second half-site mainly affected the halflife of the protein-DNA complex in vitro [17]. Expressed R2R3 protein bound the MRE variants TAACGG, TAACGT, and TAACTG with very similar binding affinities as measured by electrophoretic mobility shift assay (EMSA). These sequences conferred strikingly different transactivation activities (GG ϾϾ TG Ͼ GT and nonfunctional TT) in a strictly Myb

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call